Mass spectrometry imaging (MSI) is a potential adjunct to histopathology. However, studies have yet to adequately test its performance and reliability. Using over 900 MSI spectra, the authors establish and validate an accurate, high-resolution metabolic profile of prostate cancer, supporting the incorporation of MSI tools into surgical pathology.
- Nicole Morse
- Tamara Jamaspishvili
- David M. Berman
